TREATMENT OF PROSTATE CANCER BY PROMOTING PDE4D7
Download Read
Applicant
Koninklijke Philips N.V.
Representative
Philips Intellectual Property & Standards
Application number
EP22204042A1
Kind
A1
Document number
4360711
Shortcuts
→Abstract
→Claims

Classifications

TREATMENT OF PROSTATE CANCER BY PROMOTING PDE4D7

4360711 - EP22204042A1 - EPO

Application Oct 27, 2022 - Publication May 01, 2024

Ralf Dieter HOFFMANN George BAILLIE

Abstract

The invention relates to a product for use in the treatment, prevention or amelioration of prostate cancer in a subject in need thereof, wherein the product induces the expression of PDE4D7 or promotes activity of phosphodiesterase 4D7. The product may be a direct or indirect activator of PDE4D7 activity or a product for expressing or promting expression of PDE4D7 an a subject. The invention further defines a kit of parts and an in vitro or ex vivo use of the product.

Description

Claims

Back to top

Statistics

Seen <100 times
Downloaded <100 times